Medical Research Laboratory, Department of Internal Medicine and Endocrinology
Aarhus C, 8000, Denmark
NCT Number: NCT01752348
The investigators hypothesize that the investigators can detect protein-sparing effects of administration of the ketone 3-hydroxybutyrate and free fatty acids during simulation of an acute inflammatory disease. The investigators use the infusion of endotoxin, US standard reference E.coli in healthy subjects as a model for inflammation / infection and to evaluate the effect on protein metabolism using different tracers and the investigators can measure the various intracellular signaling pathways of selected muscle and adipose tissue.
Looking for future studies?
Notify Me20 year–40 year
Male
Interventional
Not applicable
Aarhus C, 8000, Denmark
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 6 hours intervention period
Measurements of protein oxidation during intervention using radioactive tracer techniques.
Time frame: study day
Measurements on biopsies from muscle and fatty tissue taken on day of study
Time frame: 6 hours of intervention
University of Aarhus
Other
Effects of Free Fatty Acids and 3-hydroxybutyrate on Protein, Glucose, Lipid Metabolism and Intracellular Signals; a Study on Muscle Wasting and Metabolism During Acute Inflammation and Potential Anabolic Mechanisms.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05469048
Infections, Inflammation
Los Angeles, California, United States
View Trial DetailsNCT05213923
Infections, Inflammation
Lebanon, New Hampshire, United States
View Trial DetailsNCT03314831
Infections, Inflammation
Prague, Czechia
View Trial DetailsNCT03604731
Infections, Inflammation
View Trial Details